According to Strides Pharma's latest financial reports the company's current EPS (TTM) is -$0.30. In 2022 the company made an earnings per share (EPS) of -$0.22 an increase over its 2021 EPS that were of -$0.66.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.30 | 35.52% |
2022 | -$0.22 | -66.16% |
2021 | -$0.66 | -2262.12% |
2020 | $0.03070 | -93.26% |
2019 | $0.46 | -67.87% |
2018 | $1.42 | 294.66% |
2017 | $0.36 | -34.62% |
2016 | $0.55 | 172.22% |
2015 | $0.20 |